As of Feb 27
| -0.23 / -0.47%|
The 4 analysts offering 12-month price forecasts for AMAG Pharmaceuticals Inc have a median target of 54.50, with a high estimate of 55.00 and a low estimate of 41.00. The median estimate represents a +10.70% increase from the last price of 49.23.
The current consensus among 4 polled investment analysts is to Buy stock in AMAG Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.